Effects of diet and gliclazide on the haemostatic system of non-insulin-dependent diabetics.

No abstract is available for this paper.

• Publication year

  1981

• Venue

  British medical journal

• Publication date

  1981-10-17

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/bmj.283.6298.1018PMID 6794745PMCID PMC1507242
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Plasma levels of beta-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo

  1981cited by this paper
• Hematologic alterations in diabetes mellitus.

  1981cited by this paper
• Plasma levels of beta-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo.

  1981cited by this paper
• Haemostatic changes in diabetic coma

  1981cited by this paper
• Effect of metabolic control with insulin on plasma von Willebrand factor activity (VIIIR:WF) in diabetes mellitus.

  1980cited by this paper
• Anti-platelet effects of long-term treatment with gliclazide in diabetic patients.

  1979cited by this paper
• Diabetes Mellitus: A new look at diagnostic criteria

  1979cited by this paper
• Diabetes mellitus: A new look at diagnostic criteria

  1979cited by this paper
• Platelet Factor 4, β-Thromboglobulin, Malondialdehyde Formation and Blood Lipids in Patients With Diabetes Mellitus

  1979cited by this paper
• Effect on platelet adhesiveness in diabetics after long-term treatment with a new oral hypoglycaemic agent, gliclazide.

  1978cited by this paper
• Platelet Functions in Diabetes Mellitus

  1978cited by this paper
• Physiological mechanisms in coagulation and fibrinolysis.

  1977cited by this paper
• The antiheparin effect of alpha1-acid glycoprotein and platelet material, evaluated by the heparin thrombin clotting time.

  1977cited by this paper
• Reversible hematologic sequelae of diabetes mellitus.

  1977cited by this paper
• Blood glycoprotein levels in diabetes mellitus

  1976cited by this paper
• Synthesis of antihemophilic factor antigen by cultured human endothelial cells.

  1973cited by this paper
• Platelet factor-4--methods of study.

  1972cited by this paper
• Platelet Factor 4 (PF4) Release during Human Platelet Aggregation in Diabetic Patients

  1970cited by this paper
• Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.

  1966cited by this paper
• Immunochemical quantitation of antigens by single radial immunodiffusion.

  1965cited by this paper
• Studies on the nature of the circulating anticoagulant directed against antihemophilic factor: with notes on an assay for anthemophilic factor.

  1962cited by this paper
• Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. III. Demonstration of abnormal clot structure by electron microscopy.

  1962cited by this paper
• Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. II. The significance, mechanism and consequences of defective fibrin polymerization.

  1962cited by this paper
• Studies on the fibrinolytic system in the euglobulin fraction of human plasma. A. Methodological study. B. Application of the methods.

  1961cited by this paper
• A new method for the determination of fibrinogen in small samples of plasma.

  1951cited by this paper

• Effects of oral hypoglycemic agents on platelet function.

  2015cites this paper
• Aortic endothelial cell von Willebrand factor content, and circulating plasminogen activator inhibitor-1 are increased, but expression of endothelial leukocyte adhesion molecules is unchanged in insulin-dependent diabetic BB rats.

  2000cites this paper
• Changes in the aortic endothelium and plasma von Willebrand factor levels during the onset and progression of insulin-dependent diabetes in BB rats.

  1998cites this paper
• Sulphonylurea treatment of NIDDM patients with cardiovascular disease: a mixed blessing?

  1996cites this paper
• Decreased Plasminogen Activator Inhibitor‐1 Activity in Newly Diagnosed Type 2 Diabetic Patients Following Dietary Modification

  1993cites this paper
• Impaired fibrinolytic response to increased thrombin activation in type 1 diabetes mellitus: effects of the glycosaminoglycan sulodexide.

  1993cites this paper
• Plasma t-PA and PAI-1 Antigen Concentrations in Non-Insulin Dependent Diabetic Patients: Effects of Treatment Modality on Fibrinolysis

  1992cites this paper
• Sulfonylureas in NIDDM

  1992cites this paper
• Pathophysiology of vascular disease in diabetes: effects of gliclazide.

  1991cites this paper
• The Effects of Diet and Insulin Therapy on Coagulation Factor VII, Blood Viscosity, and Platelet Release Proteins in Diabetic Patients with Secondary Sulphonylurea Failure

  1991cites this paper
• The pharmacology of oral agents used to treat diabetes mellitus

  1988cites this paper
• Effects of an oral antidiabetic drug on the fibrinolytic system of blood in insulin-treated diabetic patients.

  1988cites this paper
• Haemostatic and fibrinolytic variables in diabetics with and without thromboembolic complications.

  1987cites this paper
• Adverse Cardiovascular Effects of Sulphonylurea Drugs

  1987cites this paper
• Agregacija trombocita, fabtor VIII i fibrinogen u novootkrivenih dijabetičkih bolesnika i u bolesnika s dugotrajnim dijabetesom

  1987cites this paper
• Platelet Behaviour in Non-Insulin-Dependent Diabetes -Influence of Vascular Complications, Treatment and Metabolic Control

  1986cites this paper
• Effect of insulin therapy on coagulation and platelet function in type II (non-insulin-dependent) diabetes mellitus.

  1986cites this paper
• Treatment of type II diabetes.

  1986cites this paper
• The effects of oral stanozolol on fibrinolysis in type 2 diabetes mellitus.

  1986cites this paper
• Akathisia--or not sitting.

  1986cites this paper
• Platelet Aggregation in Non‐insulin‐dependent Diabetes is Associated with Platelet Fatty Acids

  1986cites this paper
• Glyburide: A Second‐generation Sulfonylurea Hypoglycemic Agent

  1985cites this paper
• The role of oral hypoglycemic agents in therapy and prevention of macrovascular complications.

  1985cites this paper
• Platelets and diabetic vascular disease.

  1983cites this paper
• Oral hypoglycaemic agents.

  1983cites this paper
• [Therapy with oral antidiabetics 1983].

  1983cites this paper